Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 11


Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.

Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, Hongeng S, Hacein-Bey S, Cavazzana M, Leboulch P, Payen E.

Hum Gene Ther. 2016 Feb;27(2):148-65. doi: 10.1089/hum.2016.007.


Progress and challenges in viral vector manufacturing.

van der Loo JC, Wright JF.

Hum Mol Genet. 2016 Apr 15;25(R1):R42-52. doi: 10.1093/hmg/ddv451. Epub 2015 Oct 30. Review.


Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies.

Wang X, Rivière I.

Cancer Gene Ther. 2015 Mar;22(2):85-94. doi: 10.1038/cgt.2014.81. Epub 2015 Feb 27. Review.


Optimization of lentiviral vector production using polyethylenimine-mediated transfection.

Tang Y, Garson K, Li L, Vanderhyden BC.

Oncol Lett. 2015 Jan;9(1):55-62. Epub 2014 Nov 7.


Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.

Negre O, Bartholomae C, Beuzard Y, Cavazzana M, Christiansen L, Courne C, Deichmann A, Denaro M, de Dreuzy E, Finer M, Fronza R, Gillet-Legrand B, Joubert C, Kutner R, Leboulch P, Maouche L, Paulard A, Pierciey FJ, Rothe M, Ryu B, Schmidt M, von Kalle C, Payen E, Veres G.

Curr Gene Ther. 2015;15(1):64-81.


Optimised concentration and purification of retroviruses using membrane chromatography.

McNally DJ, Darling D, Farzaneh F, Levison PR, Slater NK.

J Chromatogr A. 2014 May 2;1340:24-32. doi: 10.1016/j.chroma.2014.03.023. Epub 2014 Mar 15.


Production of lentiviral vectors for transducing cells from the central nervous system.

Li M, Husic N, Lin Y, Snider BJ.

J Vis Exp. 2012 May 24;(63):e4031. doi: 10.3791/4031.


Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13.

Ou W, Marino MP, Suzuki A, Joshi B, Husain SR, Maisner A, Galanis E, Puri RK, Reiser J.

Hum Gene Ther Methods. 2012 Apr;23(2):137-47. doi: 10.1089/hgtb.2012.054. Epub 2012 May 21.


Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration.

Zimmermann K, Scheibe O, Kocourek A, Muelich J, Jurkiewicz E, Pfeifer A.

BMC Biotechnol. 2011 May 20;11:55. doi: 10.1186/1472-6750-11-55.


Prolonged survival and phenotypic correction of Akp2(-/-) hypophosphatasia mice by lentiviral gene therapy.

Yamamoto S, Orimo H, Matsumoto T, Iijima O, Narisawa S, Maeda T, Millán JL, Shimada T.

J Bone Miner Res. 2011 Jan;26(1):135-42. doi: 10.1002/jbmr.201.


Recent advances in lentiviral vector development and applications.

Mátrai J, Chuah MK, VandenDriessche T.

Mol Ther. 2010 Mar;18(3):477-90. doi: 10.1038/mt.2009.319. Epub 2010 Jan 19. Review. Erratum in: Mol Ther. 2010 May;18(5):1055.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk